FR5531M - - Google Patents

Info

Publication number
FR5531M
FR5531M FR69046915A FR69046915A FR5531M FR 5531 M FR5531 M FR 5531M FR 69046915 A FR69046915 A FR 69046915A FR 69046915 A FR69046915 A FR 69046915A FR 5531 M FR5531 M FR 5531M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR69046915A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR69046915A priority Critical patent/FR5531M/fr
Application granted granted Critical
Publication of FR5531M publication Critical patent/FR5531M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR69046915A 1966-02-08 1966-02-08 Expired FR5531M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR69046915A FR5531M (fr) 1966-02-08 1966-02-08

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR69046915A FR5531M (fr) 1966-02-08 1966-02-08

Publications (1)

Publication Number Publication Date
FR5531M true FR5531M (fr) 1967-11-13

Family

ID=9694557

Family Applications (1)

Application Number Title Priority Date Filing Date
FR69046915A Expired FR5531M (fr) 1966-02-08 1966-02-08

Country Status (1)

Country Link
FR (1) FR5531M (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7432305B2 (en) 2005-09-15 2008-10-07 Edison Pharmaceuticals, Inc. Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9399612B2 (en) 2008-09-10 2016-07-26 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
US9447006B2 (en) 2005-06-01 2016-09-20 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9447006B2 (en) 2005-06-01 2016-09-20 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US11021424B2 (en) 2005-06-01 2021-06-01 Ptc Therapeutics, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US7432305B2 (en) 2005-09-15 2008-10-07 Edison Pharmaceuticals, Inc. Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9932286B2 (en) 2006-02-22 2018-04-03 Bioelectron Technology Corporation Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9399612B2 (en) 2008-09-10 2016-07-26 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics

Similar Documents

Publication Publication Date Title
AT281852B (fr)
AU5917865A (fr)
AU424443B2 (fr)
AU428063B2 (fr)
AU421822B2 (fr)
AU417216B2 (fr)
AU415165B1 (fr)
AU414526B2 (fr)
AU433222B2 (fr)
AU5895065A (fr)
AU612166A (fr)
AU218666A (fr)
AU6703465A (fr)
AU1144366A (fr)
AU1111066A (fr)
BE693844A (fr)
BE624223A (fr)
AU414093B2 (fr)
BE694519A (fr)
BE694375A (fr)
AU407778B2 (fr)
BE693765A (fr)
BE693387A (fr)
AU433620A (fr)
BE693348A (fr)